Skip to main content
. 2020 Feb 28;10:71. doi: 10.3389/fcimb.2020.00071

Table 1.

Demographic, clinical and microbiological characteristics of the women included in the study.

Clinical characteristics Non-pregnant women (n = 129) Pregnant women (n = 67) p-valuea
Age
   Median (range, years) 39 (18–75) 29 (18–42) < 0.001
Ethnic groups
   African (black) 114 (88%) 56 (84%) 0.73b
   Caucasian (white) 12 (9.3%) 7 (10%)
   Indian 3 (2.3%) 2 (3%)
   Inter-racial/multi-racial 0 (0%) 2 (3%)
Clinical symptoms
   Abnormal vaginal discharge
      Present 22 (17%) 12 (18%) 0.88
      Absent 107 (83%) 55 (82%)
   UTI symptomsc
      Present 28 (22%) 18 (27%) 0.42
      Absent 101 (78%) 49 (73%)
HIVd status
   Positive 67 (52%) 10 (15%) <0.001b
   Negative 57 (44%) 57 (85%)
   Unknown 5 (3.9%) 0 (0%)
Vaginal microbiota (Nugent scoring)
   Nugent score 0–3 (normal vaginal microbiota) 69 (53.5%) 50 (72%) 0.016
   Nugent score 4–6 (intermediate vaginal microbiota) 20 (15.5%) 5 (7%)
   Nugent score 7–10 (BVe) 40 (31%) 12 (20%)
Vaginal microbiota (Ison-Hay criteria)
   Class I (normal vaginal microbiota) 62 (48.1%) 48 (72%) 0.013g
   Class II (intermediate vaginal microbiota) 24 (18.6%) 8 (12%)
   Class III (BV) 39 (30.2%) 11 (16%)
   Class IV (Gram-positive cocci only) 1 (0.8%) 0 (0%)
   Class 0 (Epithelial cells with no bacteria)f 3 (2.3%) 0 (0%)
a

χ2 test for independence. Significant p-values (<0.05) are indicated in bold.

b

For African vs. Caucasian and for HIV-positive vs. HIV-negative.

c

Urinary tract infection symptoms: frequent urination, hematuria, burning sensation, dysuria, nocturia.

d

HIV: Human immunodeficiency virus.

e

BV: bacterial vaginosis.

f

Equivalent to a Nugent score of 4 (intermediate vaginal microbiota).

g

Excluding classes IV and 0.